These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34300182)

  • 1. Peripheral Nervous System Involvement in Non-Primary Pediatric Cancer: From Neurotoxicity to Possible Etiologies.
    Pro S; Vinti L; Boni A; Mastronuzzi A; Scilipoti M; Velardi M; Caroleo AM; Farina E; Badolato F; Alessi I; Di Nardo G; Carai A; Valeriani M; Reale A; Parisi P; Raucci U
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
    Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA
    Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients.
    Tay N; Laakso EL; Schweitzer D; Endersby R; Vetter I; Starobova H
    Front Mol Biosci; 2022; 9():1015746. PubMed ID: 36310587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy.
    Chen X; Gan Y; Au NPB; Ma CHE
    Front Mol Neurosci; 2024; 17():1345811. PubMed ID: 38660386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centralizing the Knowledge and Interpretation of Pain in Chemotherapy-Induced Peripheral Neuropathy: A Paradigm Shift towards Brain-Centric Approaches.
    Cunha M; Tavares I; Costa-Pereira JT
    Brain Sci; 2024 Jun; 14(7):. PubMed ID: 39061400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy.
    Tender T; Rahangdale RR; Balireddy S; Nampoothiri M; Sharma KK; Raghu Chandrashekar H
    Med Oncol; 2021 Apr; 38(5):52. PubMed ID: 33796975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced neuropathy: A comprehensive survey.
    Miltenburg NC; Boogerd W
    Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.
    Fumagalli G; Monza L; Cavaletti G; Rigolio R; Meregalli C
    Front Immunol; 2020; 11():626687. PubMed ID: 33613570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
    Kachrani R; Santana A; Rogala B; Pawasauskas J
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues.
    Bae EH; Greenwald MK; Schwartz AG
    Neurotherapeutics; 2021 Oct; 18(4):2384-2396. PubMed ID: 34676514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updating your peripheral neuropathy "know-how".
    Marrs J; Newton S
    Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced peripheral neuropathy and rehabilitation: A review.
    Zhang S
    Semin Oncol; 2021 Jun; 48(3):193-207. PubMed ID: 34607709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chinese expert consensus on the diagnosis and treatment of chemotherapy-induced peripheral neuropathy (2022 edition)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2022 Sep; 44(9):928-934. PubMed ID: 36164693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update.
    Desforges AD; Hebert CM; Spence AL; Reid B; Dhaibar HA; Cruz-Topete D; Cornett EM; Kaye AD; Urits I; Viswanath O
    Biomed Pharmacother; 2022 Mar; 147():112671. PubMed ID: 35104697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-Induced Peripheral Neuropathy.
    Chen CS; Hertz DL
    Handb Exp Pharmacol; 2023; 277():299-337. PubMed ID: 36253554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy.
    Li Y; Lustberg MB; Hu S
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
    Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
    Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy.
    Hung HW; Liu CY; Chen HF; Chang CC; Chen SC
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34073174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.
    Selvy M; Pereira B; Kerckhove N; Busserolles J; Farsi F; Guastella V; Merle P; Pezet D; Balayssac D
    Support Care Cancer; 2021 Jul; 29(7):4033-4043. PubMed ID: 33403401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.